计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| H413730-5mg |
5mg |
现货 ![]() |
| |
| H413730-10mg |
10mg |
现货 ![]() |
| |
| H413730-25mg |
25mg |
现货 ![]() |
| |
| H413730-50mg |
50mg |
现货 ![]() |
| |
| H413730-100mg |
100mg |
现货 ![]() |
| |
| H413730-200mg |
200mg |
现货 ![]() |
|
| 英文别名 | N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | HPOB |
| 生化机理 | HPOB 是一种强效、选择性 HDAC6 抑制剂,IC50 为 56 nM,选择性是其他 HDAC 的 30 倍以上。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
HPOB 是一种高选择性HDAC6抑制剂,IC50为 56 nM,其选择性是其他 HDAC 的 30 倍以上。它提高 DNA 损伤抗癌药物在转化细胞中的有效性。 修改 分子式下标C17H18N2O4 Information HPOB is a potent, selectiveHDAC6inhibitor withIC50of 56 nM, >30-fold selectivity over other HDACs. Targets HDAC6 ; HDAC3 ; HDAC8 ; HDAC1 ; HDAC10 14965,56 nM; 1.7 μM; 2.8 μM; 2.9 μM; 3.0 μM In vitro In normal (HFS) and transformed (LNCaP, A549, and U87) cells, HPOB induces acetylation of α-tubulin, however, not histones, and inhibits cell growth, however, not viability. In HFS cells, HPOB enhances transformed cell death induced by etoposide, doxorubicin, or SAHA. HPOB also enhancing etoposide-induced transformed cell death via the apoptotic pathway in transformed cells. In vivo In mice bearing CWR22 human prostate cancer xenografts, HPOB (300 mg/kg/d i.p.), when in combination with SAHA, causes suppression of the growth of established tumors, while produces no significant suppression when used alone. Cell Research(from reference) Cell lines:HFS, A549, LNCaP, and U87 cells Concentrations:~32 μM Incubation Time:72 hours |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | N-hydroxy-4-[2-[N-(2-hydroxyethyl)anilino]-2-oxoethyl]benzamide |
| INCHI | 1S/C17H18N2O4/c20-11-10-19(15-4-2-1-3-5-15)16(21)12-13-6-8-14(9-7-13)17(22)18-23/h1-9,20,23H,10-12H2,(H,18,22) |
| InChi Key | RFAZNTABYJYOAR-UHFFFAOYSA-N |
| Smiles | C1=CC=C(C=C1)N(CCO)C(=O)CC2=CC=C(C=C2)C(=O)NO |
| Isomeric SMILES | C1=CC=C(C=C1)N(CCO)C(=O)CC2=CC=C(C=C2)C(=O)NO |
| 分子量 | 314.34 |
| Reaxy-Rn | 23515709 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=23515709&ln= |
| 溶解性 | Solubility (25°C) In vitro DMSO: 62 mg/mL (197.23 mM); Ethanol: 38 mg/mL warmed with 50ºC Water: bath (120.88 mM); Water: Insoluble; |
|---|---|
| 分子量 | 314.340 g/mol |
| XLogP3 | 1.000 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 314.127 Da |
| 单同位素质量Monoisotopic Mass | 314.127 Da |
| 拓扑极表面积Topological Polar Surface Area | 89.900 Ų |
| 重原子数Heavy Atom Count | 23 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 388.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |